Sales J., D. C. e. a. (2005). "Brazil: an epidemiological study in intensive care units."
Critical Care 9 (S1): 197.
Sato, M., H. Sano, et al. (2003). "Direct binding of Toll-like receptor 2 to zymosan, and
zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-
regulated by lung collectin surfactant protein A." J Immunol 171(1): 417-25.
Shuto, T., A. Imasato, et al. (2002). "Glucocorticoids synergistically enhance
nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via
a negative cross-talk with p38 MAP kinase." J Biol Chem 277(19): 17263-70.
Silva, E., N. Akamine, et al. (2006). "Surviving sepsis campaign: a project to change
sepsis trajectory." Endocr Metab Immune Disord Drug Targets 6(2): 217-22.
Silva, E., A. Pedro Mde, et al. (2004). "Brazilian Sepsis Epidemiological Study
(BASES study)." Crit Care 8(4): R251-60.
Takeuchi, O., T. Kawai, et al. (2001). "Discrimination of bacterial lipoproteins by Toll-
like receptor 6." Int Immunol 13(7): 933-40.
Takeuchi, O., S. Sato, et al. (2002). "Cutting edge: role of Toll-like receptor 1 in
mediating immune response to microbial lipoproteins." J Immunol 169(1): 10-4.
Takeuchi, O., K. Hoshino, et al. (1999). "Differential roles of TLR2 and TLR4 in
recognition of gram-negative and gram-positive bacterial cell wall components."
Immunity 11(4): 443-51.
Tatsuta, K., S. Tanaka, et al. (2008). "Complete elimination of established
neuroblastoma by synergistic action of gamma-irradiation and DCs treated with
rSeV expressing interferon-beta gene." Gene Ther.
Teles, J. M., E. Silva, et al. (2008). "Surviving sepsis campaign in Brazil." Shock 30
Suppl 1: 47-52.
Wang, T. S. and J. C. Deng (2008). "Molecular and cellular aspects of sepsis-induced
immunosuppression." J Mol Med 86(5): 495-506.
Weighardt, H., S. Kaiser-Moore, et al. (2002). "Cutting edge: myeloid differentiation
factor 88 deficiency improves resistance against sepsis caused by polymicrobial
infection." J Immunol 169(6): 2823-7.
Wen, H., Y. Dou, et al. (2008). "Epigenetic regulation of dendritic cell-derived
interleukin-12 facilitates immunosuppression after a severe innate immune
response." Blood 111(4): 1797-804.
Wen, H., C. M. Hogaboam, et al. (2006). "Severe sepsis exacerbates cell-mediated
immunity in the lung due to an altered dendritic cell cytokine profile." Am J
Pathol 168(6): 1940-50.